Movement Alert｜Liquidia Technologies Inc Intraday Rise 4.07%, analyst target increases and revenue optimism extend post-earnings momentum

Market Focus11-12 23:43

On November 12, Liquidia Technologies Inc rose 4.07% in Regular Trading, trading at $57.6 per share, with turnover of $25.0313 million.

The clearest catalyst behind the move was continued post-earnings follow-through as the market kept trading on analyst price-target increases and higher revenue expectations after the company’s third-quarter update.

Recent disclosures showed third-quarter revenue of $225.3 million, above the $214.2 million consensus, while YUTREPIA net product sales reached $222.7 million and October patient shipments hit a monthly high. Although the company reported a loss of $2.64 per share, that result was heavily affected by an about $389.7 million litigation settlement charge tied to United Therapeutics. After the report, BofA raised its target price to $54 from $42, Needham raised its target to $66 from $58, and BTIG reiterated Buy with an $87 target, reinforcing sentiment that improving commercialization and lower legal uncertainty matter more to investors than the headline loss.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment